Molecular Mechanism Discovery of Acacetin Against Cancers: Insights from Network Pharmacology and Molecular Docking

Area of Science:

• Natural Product Chemistry
• Molecular Pharmacology
• Computational Biology

Background:

• Acacetin, a flavonoid, exhibits anticancer properties by affecting oncogenic signaling, angiogenesis, and cell death.
• There is a growing need for multi-target cancer therapeutics.
• Understanding the molecular mechanisms of phytochemicals is crucial for drug development.

Purpose of the Study:

• To investigate the multi-target anticancer mechanisms of acacetin using an integrative approach.
• To identify key molecular targets of acacetin through network pharmacology and molecular docking.
• To link computational predictions with experimental validation for therapeutic insights.

Main Methods:

• Network pharmacology analysis to predict potential targets of acacetin.
• Molecular docking simulations to assess binding affinities with predicted targets.
• Integration of computational findings with existing experimental data for validation.

Main Results:

• Identified epidermal growth factor receptor (EGFR), signal transducer and activator of transcription 3 (STAT3), and AKT (protein kinase B) as central, experimentally supported targets of acacetin.
• Demonstrated acacetin's ability to modulate multiple oncogenic pathways.
• Validated computational predictions through existing experimental evidence.

Conclusions:

• Acacetin functions as a multi-target therapeutic agent against cancer.
• The identified targets (EGFR, STAT3, AKT) are crucial for acacetin's anticancer effects.
• This integrative approach provides a framework for understanding acacetin's mechanisms and its translational potential in cancer therapy.